EXHIBIT 31.1 CERTIFICATION OF THE CHIEF EXECUTIVE OFFICER AND CHIEF FINANCIAL OFFICER PURSUANT TO RULE 13a-14 OF THE SECURITIES EXCHANGE ACT OF 1934, AS ADOPTED PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002 I, Anderson L. McCabe, as CEO and CFO of Opt-Sciences Corporation, certify that:1.
    I have reviewed this quarterly report of Opt-Sciences Corporation;2.
    Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact
      necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;3.
    Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of Opt-Sciences Corporation as of, and for, the periods presented in this report;4.
    I am responsible for establishing and maintaining disclosure
      controls and procedures (as defined in Exchange Act Rules 13a-15(e) and
      15d-15(e)) and internal control over financial reporting (as defined in
      Exchange Act Rules 13a-15(f) and 15d-15(f)) for Opt-Sciences Corporation
      and have:(a)
    Designed such disclosure controls and procedures, or caused such
      disclosure controls and procedures to be designed under my supervision, to
      ensure that material information relating to Opt-Sciences Corporation,
      including its consolidated subsidiaries, is made known to me by others
      within those entities, particularly during the period in which this report
      is being prepared;(b)
    Designed such internal control over financial reporting, or caused
      such internal control over financial reporting to be designed under my
      supervision, to provide reasonable assurance regarding the reliability of
      financial reporting and the preparation of financial statements for
      external purposes in accordance with generally accepted accounting
      principles;(c)
    Evaluated the effectiveness of Opt-Sciences Corporation's disclosure
      controls and procedures and presented in this report my conclusions about
      the effectiveness of the disclosure controls and procedures, as of the end
      of the period covered by this report based on such evaluation; and(d)
    Disclosed in this report any change in Opt-Sciences Corporation's
      internal control over financial reporting that occurred during
      Opt-Sciences Corporation's most recent fiscal quarter that has materially
      affected, or is reasonably likely to materially affect, Opt-Sciences
      Corporation's internal control over financial reporting; and5.
    I have disclosed, based on my most
      recent evaluation of internal control over financial reporting, to
      Opt-Sciences Corporation's auditors and the audit committee of
      Opt-Sciences Corporation's board of directors (or persons performing the
      equivalent functions):(a)
    All significant deficiencies and material weaknesses in the design or
      operation of internal control over financial reporting which are
      reasonably likely to adversely affect Opt-Sciences Corporation's ability
      to record, process, summarize and report financial information; and(b)
    Any fraud, whether or not material, that involves management or other
      employees who have a significant role in Opt-Sciences Corporation's
      internal control over financial reporting. Opt-Sciences Corporation/s/ Anderson L.
      McCabeAnderson L. McCabeChief Executive Officer &Chief Financial OfficerJune 15, 2015